In a coordinated five‑laboratory study of ~200 mice, psilocybin (2 mg/kg IP) produced robust, replicable acute behavioural effects — increased anxiety- and avoidance-related behaviour and reduced fear expression — but did not reproducibly produce persistent (24 h) anxiolytic, antidepressant, fear‑extinction or pro‑social effects. The multi‑institutional design therefore both delineates the reliable acute actions of psilocybin and provides a model for improving reproducibility in psychedelic research.
- Published
- Journal
- Biorxiv
- Authors
- Lu, O. D., White, K., Raymond, K., Liu, C., Klein, A. S., Green, N., Vaillancourt, S., Gallagher, A., Shindy, L., Li, A., Wallquist, K., Li, R., Zou, M., Casey, A. B., Cameron, L. P., Pomrenze, M. B., Sohal, V., Kheirbek, M. A., Gomez, A. M., Lammel, S., Heifets, B. D., Malenka, R.